Your session is about to expire
← Back to Search
Exendin (9-39) for Low Blood Sugar After Bariatric Surgery
Study Summary
This trial will test whether GLP-1 is the cause of hypoglycemia in a subset of bariatric surgery patients.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 4 trial • 329 Patients • NCT03101930Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I have not taken part in other studies or taken investigational drugs recently.I am a woman who can have children and will use two forms of birth control or practice abstinence.I am taking medication that affects my blood sugar levels.My BMI is between 25-40 and I have severe low blood sugar episodes after weight-loss surgery.You have a mental illness that is not well managed.I do not have severe heart, kidney, liver issues, severe lung disease, very low blood count, or very high blood pressure.I haven't had a fever, infection, stomach issues, or bone injuries in the last week.My blood sugar or HbA1c levels are high even though I'm taking Metformin.I am between 18 and 65 years old.
- Group 1: Exendin(9-39)
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Exendin (9-39) been sanctioned for use by the FDA?
"With only a few studies to support its safety and efficacy, Exendin (9-39) was assigned an initial score of 1."
What criteria must I meet in order to qualify for participation in this research?
"This trial is recruiting 30 individuals who have been diagnosed with severe symptomatic hypoglycemia following bariatric surgery and are aged between 18-65. Additional requisites include a BMI ranging from 25-40 for all male/female participants."
Could you please detail the prior research conducted with Exendin (9-39)?
"Currently, there is a single clinical trial for Exendin (9-39). The majority of the participants are based in Stanford, California yet there exists an additional location hosting this study. Unfortunately, no Phase 3 trials have been initiated as of now."
Is enrollment for this clinical trial still available?
"This particular trial is no longer looking for participants. It was initially posted on February 1st 2014 and last edited July 1st 2016. For people searching for related studies, there are 86 clinical trials actively recruiting patients with hypoglycemia and one research project targeting Exendin (9-39)."
Is the trial open to individuals below seventy years of age?
"The cutoff date for inclusion in this trial is within the 18-65 age range. However, if you are younger than 18 or older than 65 there are still 13 and 60 studies respectively that you may be eligible to participate in."
What is the enrollment rate of this clinical investigation?
"Currently, this medical trial is not accepting new patients. It was initially posted on February 1st 2014 and most recently edited July 1st 2016. If you are searching for other studies, there are 86 active trials recruiting individuals with hypoglycemia and one study offering Exendin (9-39)."
Share this study with friends
Copy Link
Messenger